Shringar House of Mangalsutra Schedules Investor Plant Visit for May 4-5, 2026
Shringar House of Mangalsutra Limited has officially announced a plant visit interaction with investors and analysts scheduled for May 4-5, 2026, at its Kandivali facility in Mumbai. The company notified both NSE (Symbol: SHRINGARMS) and BSE (Scrip Code: 544512) on April 24, 2026, in compliance with SEBI Regulation 30(6), with discussions to be based solely on publicly available information.

*this image is generated using AI for illustrative purposes only.
Shringar House of Mangalsutra Limited has announced an upcoming plant visit interaction with investors and analysts, scheduled for May 4-5, 2026. The company informed both NSE and BSE about this event on April 24, 2026, in compliance with regulatory requirements.
Event Details
The investor interaction is organized as per the following schedule:
| Parameter: | Details |
|---|---|
| Event Type: | Plant Visit (Group of Investors) |
| Date: | May 4-5, 2026 (Monday & Tuesday) |
| Location: | Kandivali, Mumbai |
| Mode: | In person |
| NSE Symbol: | SHRINGARMS |
| BSE Scrip Code: | 544512 |
Regulatory Compliance
The announcement was made pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III of the said Regulations. Company Secretary and Compliance Officer Rachit S Sinha signed the notification on April 24, 2026, ensuring proper adherence to disclosure norms.
Discussion Framework
The company has clarified that discussions during the plant visit will be based exclusively on publicly available information. No unpublished price-sensitive information is intended to be discussed during the visit, maintaining transparency and regulatory compliance.
Operational Flexibility
Shringar House of Mangalsutra Limited has noted that the meeting schedule may undergo changes due to exigencies on the part of participants or the company. This provision allows for necessary adjustments while maintaining the commitment to investor engagement.
Company Information
The company operates from its registered office at Unit No. B-1, Lower Ground Floor, Jewel World (Cotton Exchange Building), Kalbadevi Road, Mumbai. The manufacturing facility is located at Ground, 1st & Part of 2nd Floor, Gala No. 21 ABCD, Government Industrial Estate, Charkop, Kandivali West, Mumbai. The plant visit will provide investors with firsthand insights into the company's manufacturing operations and business processes.
What expansion plans or capacity upgrades might Shringar House reveal during the plant visit that could impact future production volumes?
How could the insights gained from this investor interaction influence the company's stock performance and analyst recommendations in the coming quarters?
What new product lines or technological innovations in the mangalsutra segment might be showcased during the manufacturing facility tour?

































